Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...

NovoPen ®, the first insulin pen injector, was introduced in 1985 ... as conventional insulin regimens employing syringes. The published evidence identified also showed that insulin ...

Becton, Dickinson and Company (NYSE:BDX) authorized to pursue a plan to separate BD’s Biosciences and Diagnostic Solutions ...

Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...

Embecta Corp (EMBC) reports a mixed quarter with revenue declines but strong growth in safety products and contract manufacturing, while focusing on debt reduction and strategic partnerships.

The trade show floor offers a firsthand look at how market trends shape current design and manufacturing innovations. Attendees at MD&M West 2025 could navigate emerging trendlines, shifting industry ...

Q1 2025 Earnings Call Transcript February 6, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.65, ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

Jabil acquires Pharmaceutics International to enhance commercial prospects in the emerging market of CDMO services.